Difficult-to-Dose Opioids and the Risk Evaluation Mitigation Strategy
Difficult-to-Dose Opioids and the Risk Evaluation Mitigation Strategy
On behalf of patient safety considerations, providers must receive the support for safely switching patients to and from oral fentanyl products. This could be accomplished with the upcoming implementation of the Risk Evaluation Mitigation Strategy (REMS) for opioids.
Abstract and Introduction
Introduction
On behalf of patient safety considerations, providers must receive the support for safely switching patients to and from oral fentanyl products. This could be accomplished with the upcoming implementation of the Risk Evaluation Mitigation Strategy (REMS) for opioids.
Source...